Healthcare Services

Genetic Toxicology Testing Market Developments and Growth Opportunities Across 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Genetic Toxicology Testing Market Between 2026 And 2030?

The genetic toxicology testing market size has experienced rapid expansion in recent years. This market is expected to expand from $1.8 billion in 2025 to $1.98 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. The historical growth of this market can be linked to factors such as regulatory safety requirements, the rise in pharmaceutical research and development, the early implementation of in vivo testing, industrial chemical surveillance, and various environmental health investigations.

The genetic toxicology testing market is anticipated to experience substantial growth in the coming years. This market is projected to reach $2.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. Several factors are contributing to this expansion over the forecast period, including a move towards alternative testing methods, more stringent regulatory frameworks, an increase in biologics development, the demand for safer chemicals, and the broadening application of toxicogenomics. Key trends during this period encompass the expanded use of genotoxicity testing in drug development, the rising adoption of in vitro genetic toxicology assays, heightened regulatory scrutiny on chemical safety testing, the widening scope of environmental genotoxicity assessment, and a greater need stemming from pharmaceutical safety studies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What Drivers Are Influencing The Genetic Toxicology Testing Market?

The genetic toxicology testing market is anticipated to expand due to the growing need for personalized medicine. This medical approach involves customizing healthcare choices, methods, treatments, and goods for each patient, considering their anticipated reaction or likelihood of disease. Advances in genetics, deeper insights into diseases, the availability of diagnostic tools utilizing biomarkers, healthcare programs focused on value, and its incorporation into clinical settings and research have all contributed to a surge in the personalized medicine market. Genetic toxicology testing plays a vital role in personalized medicine by offering crucial data on genetic differences, vulnerability to genotoxic substances, and how patients respond to treatment. As an illustration, in February 2024, the US-based non-profit, Personalized Medicine Coalition, reported that the FDA sanctioned 16 novel personalized medicines for rare disease patients in 2023, an increase from six in 2022. Consequently, the rising demand for personalized medicine is a key driver for the genetic toxicology testing market.

Which Market Segments Are Examined In The Genetic Toxicology Testing Market Study?

The genetic toxicology testing market covered in this report is segmented –

1) By Testing Method: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent)

Which Trends Are Shaping The Future Of The Genetic Toxicology Testing Market?

Major companies operating in the genetic toxicology testing market are concentrating on creating advanced drug screening platforms, such as high throughput transcriptomics, to enhance the precision and effectiveness of identifying potential genetic toxins. High throughput transcriptomics describes a technology-driven method that facilitates the large-scale measurement of gene expression (the transcriptome) across numerous samples simultaneously, typically employing techniques like RNA sequencing (RNA-seq). This approach allows scientists to evaluate, in a high-throughput manner, how various compounds (e.g., drugs or chemicals) alter global cellular gene expression, thereby assisting in the prediction of toxicological outcomes, mechanisms of action (MOA), and potential genotoxicity. As an illustration, in September 2024, Toxys, a Netherlands-based biotech firm specializing in in vitro toxicology solutions, unveiled MutaTracker. This mammalian cell-based mutagenicity and genotoxicity assay incorporates its established ToxTracker reporter system with error-corrected single molecule mutation sequencing (SMM seq). The platform offers ultra-sensitive detection of point mutations (as rare as 1 in 107 bases) and delivers comprehensive insight into the genotoxic mode of action, leading to improved accuracy and fewer false positives compared to conventional cytogenetic assays.

Who Are The Primary Competitors In The Genetic Toxicology Testing Market?

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

Read the full genetic toxicology testing market report here:

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Genetic Toxicology Testing Market?

North America was the largest region in the genetic toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Genetic Toxicology Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp

Browse Through More Reports Similar to the Global Genetic Toxicology Testing Market 2026, By The Business Research Company

Genetic Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Genomics Services Global Market Report

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Direct To Consumer Dtc Genetic Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795